Inhibitory Effect of New Semisynthetic Usnic Acid Derivatives on Human Tyrosyl-DNA Phosphodiesterase 1

Abstract

Usnic acid, a lichen secondary metabolite produced by a whole number of lichens, has attracted the interest of researchers owing to its broad range of biological activity, including antiviral, antibiotic, anticancer properties, and it possessing a certain toxicity. The synthesis of new usnic acid derivatives and the investigation of their biological activity may lead to the discovery of compounds with better pharmacological and toxicity profiles. In this context, a series of new usnic acid derivatives comprising a terpenoid moiety were synthesized, and their ability to inhibit the catalytic activity of the human DNA repair enzyme tyrosyl-DNA phosphodiesterase 1 was investigated. The most potent compounds (15a, 15b, 15g, and 16a, 16b, 16g) had IC₅₀ values in the range of 0.33 – 2.7 µM. The inhibitory properties were mainly dependent on the flexibility and length of the terpenoid moiety, but not strongly dependent on the configuration of the asymmetric centers. The synthesized derivatives showed low cytotoxicity against human cell lines in an MTT assay. They could be used as a basis for the development of more effective anticancer therapies when combined with topoisomerase 1 inhibitors.

Key words

Usneaceae - Usnea barbata - usnic acid - terpenophenols - tyrosyl-DNA phosphodiesterase 1 - Tdp1 inhibitor

• References

• 1 Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 2016; 79: 629-661
• 2 Nicolaou KC. Advancing the drug discovery and development process. Angew Chem Int Ed 2014; 53: 9128-9140
• 3 Kuzakov EV, Shmidt EN. Synthesis of terpenophenols via direct alkylation of phenols by terpenes. Chem Nat Comp 2000; 36: 245-257
• 4 Brenneisen R. Chemistry and Analysis of Phytocannabinoids and other Cannabis Constituents. In: Elsohly M. ed. Marijuana and the Cannabinoids. Totowa, NY: Humana Press; 2007: 17-49
• 5 Shevchenko OG, Plusnina SN, Shishkina LN, Chukicheva IY, Fedorova IV, Kuchin AV. Membrane protective properties of isobornylphenols – a new class of antioxidants. Biochemistry (Mosc) 2013; 30: 302-312
• 6 Logvinov SV, Plotnikov MB, Zdankina AA, Smolyakova VI, Ivanov IS, Kuchin AV, Chukicheva IV, Varakuta EY. Morphological changes in retinal neurons in streptozotocin induced diabetes mellitus and their correction with an isobornylphenol derivative. Neurosci Behav Physiol 2010; 40: 779-782
• 7 Plotnikov MB, Smolyakova VI, Ivanov IS, Kuchin AV, Chukicheva IJ, Buravlev EV, Krasnov EA. Synthesis and biological activity of O-isobornylphenol derivatives. Pharmaceut Chem J 2011; 44: 530-533
• 8 Luzina OA, Salakhutdinov NF. Biological activity of usnic acid and its derivatives: Part 1. Activity against unicellular organisms. Russ J Bioorg Chem 2016; 42: 115-132
• 9 Luzina OA, Salakhutdinov NF. Biological activity of usnic acid and its derivatives: Part 2. Effects on higher organisms. Molecular and physicochemical aspects. Russ J Bioorg Chem 2016; 42: 249-268
• 10 Luzina OA, Salakhutdinov NF. Usnic acid and its derivatives for pharmaceutical use: a patent review (2000–2017). Expert Opin Ther Pat 2018; 28: 477-491
• 11 Zakharenko A, Luzina O, Koval O, Nilov D, Gushchina I, Dyrkheeva N, Švedas V, Salakhutdinov N, Lavrik O. Tyrosyl-DNA phosphodiesterase 1 inhibitors: usnic acid enamines enhance the cytotoxic effect of camptothecin. J Nat Prod 2016; 79: 2961-2967
• 12 Zakharenko AL, Luzina OA, Sokolov DN, Zakharova OD, Rakhmanova ME, Chepanova AA, Dyrkheeva NS, Lavrik OI, Salakhutdinov NF. Usnic acid derivatives are effective inhibitors of tyrosyl-DNA phosphodiesterase 1. Russ J Bioorg Chem 2017; 43: 84-90
• 13 Comeaux EQ, van Waardenburg RC. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target. Drug Metab Rev 2014; 46: 494-507
• 14 Dancey J, Eisenhauer EA. Current perspectives on camptothecins in cancer treatment. Br J Cancer 1996; 74: 327-338
• 15 Fujita K, Kubota Y, Ishida H, Sasaki Y. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol 2015; 21: 12234-12248
• 16 Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006; 6: 789-802
• 17 Interthal H, Pouliott JJ, Champoux JJ. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci U S A 2001; 98: 12009-12014
• 18 Yang SW, Burgin jr. AB, Huizenga BN, Robertson CA, Yao KC, Nash HA. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci U S A 1996; 93: 11534-11539
• 19 Jilani A, Ramotar D, Slack C, Ong C, Yang XM, Scherer SW, Lasko DD. Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3′-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage. J Biol Chem 1999; 274: 24176-24186
• 20 Pouliot JJ, Yao KC, Robertson CA, Nash HA. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science 1999; 286: 552-555
• 21 Beretta GL, Cossa G, Gatti L, Zunino F, Perego P. Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment. Curr Med Chem 2010; 17: 1500-1508
• 22 Dexheimer TS, Antony S, Marchand C, Pommier Y. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy. Anticancer Agents Med Chem 2008; 8: 381-389
• 23 Huang SN, Pommier Y, Marchand C. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitors. Expert Opin Ther Pat 2011; 21: 1285-1292
• 24 Huang HC, Liu J, Baglo Y, Rizvi I, Anbil S, Pigula M, Hasan T. Mechanism-informed repurposing of minocycline overcomes resistance to topoisomerase inhibition for peritoneal carcinomatosis. Mol Cancer Ther 2018; 17: 508-520
• 25 Huang SY, Murai J, Dalla Rosa I, Dexheimer TS, Naumova A, Gmeiner WH, Pommier Y. TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res 2013; 41: 7793-7803
• 26 El-Khamisy SF, Hartsuiker E, Caldecott KW. TDP1 facilitates repair of ionizing radiation-induced DNA single-strand breaks. DNA Repair (Amst) 2007; 6: 1485-1495
• 27 Takagi M, Ueda J, Hwang J, Hashimoto J, Izumikawa M, Murakami H, Sekido Y, Shin-ya K. Tyrosyl-DNA phosphodiesterase 1 inhibitor from an anamorphic fungus. J Nat Prod 2012; 75: 764-767
• 28 Tian L, Feng Y, Tran TD, Shimizu Y, Pfeifer T, Forster PI, Quinn RJ. Tyrosyl-DNA phosphodiesterase I inhibitors from the Australian plant Macropteranthes leichhardtii . J Nat Prod 2015; 78: 1756-1760
• 29 Tian L, Feng Y, Tran TD, Shimizu Y, Pfeifer T, Vu HT, Quinn RJ. Achyrodimer F, a tyrosyl-DNA phosphodiesterase I inhibitor from an Australian fungus of the family Cortinariaceae. Bioorg Med Chem Lett 2017; 27: 4007-4010
• 30 Davies DR, Interthal H, Champoux JJ, Hol WG. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. J Mol Biol 2002; 324: 917-932
• 31 Davies DR, Interthal H, Champoux JJ, Hol WG. The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. Structure 2002; 10: 237-248
• 32 Dexheimer TS, Gediya LK, Stephen AG, Weidlich I, Antony S, Marchand C, Interthal H, Nicklaus M, Fisher RJ, Njar VC, Pommier Y. 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors. J Med Chem 2009; 52: 7122-7131
• 33 Conda-Sheridan M, Reddy PVN, Morrell A, Cobb BT, Marchand C, Agama K, Chergui A, Renaud A, Stephen AG, Bindu LK, Pommier Y, Cushman M. Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase i (Tdp1) and topoisomerase I (Top1). J Med Chem 2013; 56: 182-200
• 34 Sirivolu VR, Vernekar SK, Marchand C, Naumova A, Chergui A, Renaud A, Stephen AG, Chen F, Sham YY, Pommier Y, Wang Z. 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I. J Med Chem 2012; 55: 8671-8684
• 35 Zakharenko AL, Khomenko TM, Zhukova SV, Koval OA, Zakharova OD, Anarbaev RO, Lebedeva NA, Korchagina DV, Komarova NI, Vasiliev VG, Reynisson J, Volcho KP, Salakhutdinov NF, Lavrik OI. Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety. Bioorg Med Chem 2015; 23: 2044-2052
• 36 Zakharenko AL, Ponomarev KU, Suslov EV, Korchagina DV, Volcho KP, Vasilʼeva IA, Salakhutdinov NF, Lavrik OI. Inhibitory properties of nitrogen-containing adamantane derivatives with monoterpenoid fragments against tyrosyl-DNA phosphodiesterase 1. Russ J Bioorg Chem 2015; 41: 657-662
• 37 Khomenko T, Zakharenko A, Odarchenko T, Arabshahi HJ, Sannikova V, Zakharova O, Korchagina D, Reynisson J, Volcho K, Salakhutdinov N, Lavrik O. New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties. Bioorg Med Chem 2016; 24: 5573-5581
• 38 Luzina OA, Sokolov DN, Shernyukov AV, Salakhutdinov NF. Synthesis of aurones based on usninic acid. Chem Nat Comp 2012; 48: 385-391
• 39 Antony S, Marchand C, Stephen AG, Thibaut L, Agama KK, Fisher RJ, Pommier Y. Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1. Nucleic Acids Res 2007; 35: 4474-4484
• 40 Bezivin C, Tomasi S, Rouaud I, Delcros JG, Boustie J. Cytotoxic activity of compounds from the lichen: Cladonia convolute . Planta Med 2004; 70: 874-877
• 41 Shtro AA, Zarubaev VV, Luzina OA, Sokolov DN, Salakhutdinov NF. Derivatives of usnic acid inhibit broad range of influenza viruses and protect mice from lethal influenza infection. Antivir Chem Chemother 2015; 24: 92-98
• 42 Polovinka MP, Salakhutdinov NF, Panchenko MY. Method for preparing usninic acid. Russian Federation Patent 2317076; 2008.
• 43 Kiesgen de Richter R, Bonato M, Follet M, Kamenka JM. The (+)- and (−)-[2-(1,3-dithianyl)]myrtanylborane. Solid and stable monoalkylboranes for asymmetric hydroboration. J Org Chem 1990; 55: 2855-2860
• 44 Ponomarev K, Pavlova A, Suslov E, Ardashov O, Korchagina D, Nefedov A, Tolstikova T, Volcho K, Salakhutdinov N. Synthesis and analgesic activity of new compounds combining azaadamantane and monoterpene moieties. Med Chem Res 2015; 24: 4146-4156
• 45 Anikeev VI, Ilʼina IV, Volcho KP, Salakhutdinov NF. Campholene aldehyde synthesis method. Russian Federation Patent 2402522; 2010.
• 46 Davies DR, Interthal H, Champoux JJ, Hol WG. Crystal structure of a transition state mimic for tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide. Chem Biol 2003; 10: 139-147
• 47 Gushchina IV, Nilov DK, Zakharenko AL, Lavrik OI, Švedas VK. Structure modeling of human tyrosyl-DNA phosphodiesterase 1 and screening for its inhibitors. Acta Naturae 2017; 9: 59-66
• 48 Sadowski J, Gasteiger J, Klebe G. Comparison of automatic three-dimensional model builders using 639 X-ray structures. J Chem Inf Comput Sci 1994; 34: 1000-1008
• 49 Stroganov OV, Novikov FN, Stroylov VS, Kulkov V, Chilov GG. Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening. J Chem Inf Model 2008; 48: 2371-2385
• 50 Novikov FN, Stroylov VS, Stroganov OV, Kulkov V, Chilov GG. Developing novel approaches to improve binding energy estimation and virtual screening: a PARP case study. J Mol Model 2009; 15: 1337-1347
• 51 Lebedeva NA, Anarbaev RO, Kupryushkin MS, Rechkunova NI, Pyshnyi DV, Stetsenko DA, Lavrik OI. Design of a new fluorescent oligonucleotide-based assay for a highly specific real-time detection of apurinic/apyrimidinic site cleavage by tyrosyl-DNA phosphodiesterase 1. Bioconjug Chem 2015; 26: 2046-2053
• 52 Interthal H, Pouliott JJ, Champoux JJ. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci U S A 2001; 98: 12009-12014
• 53 Lebedeva NA, Rechkunova NI, Lavrik OI. AP-site cleavage activity of tyrosyl-DNA phosphodiesterase 1. FEBS Lett 2011; 585: 683-686
• 54 Mosmann TJ. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Immunol Methods 1983; 65: 55-63